Aristeia Capital’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Aristeia Capital’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-175,000	Closed	-$1.72K	–	517
2022 Q4	$1.72K	Hold	175,000	–	–	﹤0.01%	511
2022 Q3	$17K	Hold	175,000	–	–	﹤0.01%	605
2022 Q2	$13K	Hold	175,000	–	–	﹤0.01%	663
2022 Q1	$32K	Buy	+175,000	New	+$52.6K	﹤0.01%	687

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Aristeia Capital's IBER.WS Position: Q1 2023 in Review

Aristeia Capital sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 175,000 shares — an estimated $1.72K sold.

Aristeia Capital first reported a position in IBER.WS in Q1 2022 and held it in 4 quarters. The position peaked at $32K in Q1 2022. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Aristeia Capital reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Aristeia Capital sold 175,000 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $1.72K.
Aristeia Capital first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q1 2022 and held it in 4 quarters.
Aristeia Capital's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $32K in Q1 2022.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Aristeia Capital's 13F filing for Q1 2023, filed 16 May 2023.